News and Press Releases

New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute in Heidelberg

The new research team will work on multispecific biologics to target innovative pathways in the tumor microenvironment (TME) 23 October 2025 -- Heidelburg, Germany -- BioMed X, a leading innovation hub for...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: October 23, 2025

BioMed X GmbH Im Neuenheimer Feld 515 69120 Heidelberg

Teknomek partners with Monmouth Scientific: adding containment cabinets to product range

Teknomek has agreed a partnership with Monmouth Scientific to offer customers a range of containment cabinets which ensure safe handling of hazardous chemicals.  This development of the Teknomek range means...

Category:
Posted: October 22, 2025

Brunel Way, Sweetbriar Industrial Estate, Norwich, Norfolk NR3 2BD

Celerion Earns AAHRPP Full Reaccreditation for Five Years, Strengthening Commitment to Ethical Research Practices

Lincoln, Nebraska, US – Celerion proudly announces its achievement of a full AAHRPP (Association for the Accreditation of Human Research Protection Programs) reaccreditation for five years by the Council on Accreditation of...

Category:
Posted: October 21, 2025

New Medidata Report Reveals 70% of AI Users in Clinical Trials See Measurable Gains in Study Speed, Protocol Design, and Data Quality

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today released a new global research report, The State of AI in Clinical...

Category:
Posted: October 21, 2025

350 Hudson Street New York, NY 10014 USA

START, Together with HM Hospitales, Inaugurates Spain’s First Pediatric Onco-hematology Clinical Research Unit

San Antonio, TX / Madrid, Spain — The START Center for Cancer Research (“START”), the world’s largest community-based network specializing in early-phase oncology clinical trials, together with HM Hospitales, announces...

Category:
Posted: October 21, 2025

4383 Medical Dr, San Antonio, TX 78229, United States

ACG to invest $200 million in U.S. hard-shell capsule manufacturing

October 20, 2025 - ACG have announced a $200 million phased investment to establish its first empty-capsule manufacturing operations in the United States. The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta,...

Category:
Posted: October 21, 2025

D Bhabrekar Nagar Road Mumbai, Maharashtra 400067, IN

SOM Biotech secures clear registrational path for SOM3355 in Huntington’s disease after FDA End‑of‑Phase 2 Meeting

20 October 2025 -- Barcelona, Spain -- SOM Biotech, a clinical-stage company dedicated to the discovery and development of innovative therapies for rare central nervous system disorders, announces today that it...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 20, 2025

Baldiri Reixac, 4 (08028) Barcelona, Spain

Lundbeck and Contera Pharma announce research collaboration to advance RNA-targeting medicines for serious neurological conditions

20 October 2025 -- Valby, Denmark -- H. Lundbeck A/S and Contera Pharma today announced a strategic research collaboration aiming to accelerate the discovery and development of innovative oligonucleotide-based medicines...

Category: Biotechnology, Drug Discovery, Logistics, Other, Pharmaceutical
Posted: October 20, 2025

Iveco House Station Road Watford Hertfordshire WD17 1ET

Iksuda presents encouraging IKS014 Phase 1 data at ESMO

New safety, efficacy and pharmacokinetic results presented from dose escalation portion of the study Anti-tumour activity observed across all dose levels and in various tumour indications 20 October 2025 --...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 20, 2025

The Biosphere, Draymans Way, Newcastle Helix Newcastle upon Tyne NE4 5BX

NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025

NUC-7738 Synergizes with PD-1 Inhibitors to Promote Cancer Cell Death Data Reinforces Mechanism of Action along with Efficacy and Safety Profile of NUC-7738. 18 October 2025 -- Berlin, Germany --...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 18, 2025

https://www.nucana.com/

Owen Mumford launches EcoSafe® safety syringe platform – smarter for budgets and kinder to the planet

Oxford, 15 October 2025 – Medical device expert Owen Mumford has extended its 1ml safety syringe platform by adding a companion reusable autoinjector. The  EcoSafe® 1ml safety syringe (previously branded...

Category:
Posted: October 17, 2025

Brook Hill Woodstock Oxfordshire OX20 1TU

ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting

Presentation at AAO 2025 part of ongoing NEW DAY data dissemination at medical meetings 16 October 2025 -- New Jersey, US -- ANI Pharmaceuticals, Inc today announced that results from...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 16, 2025

210 Main Street West Baudette, MN 56623

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression to phase 2 clinical trials in Malawi Demonstrates Recipharm’s agility and flexibility, completing full tech transfer, scale-up and process optimisation within three...

Category: BioManufacturing, Drug Delivery, Manufacturing and Packing, Other, Pharmaceutical
Posted: October 15, 2025

Nabla Bio Signs Second Takeda Collaboration to Advance AI-Driven Design of Protein Therapeutics

Nabla to receive upfront and research cost payments in double-digit millions and eligible to receive success-based payments that may exceed $1 billion Multi-year partnership deploys Nabla Bio’s AI design and...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 14, 2025

Riverside Technology Center
 840 Memorial Dr
 Cambridge, MA 02139

Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation

14 October 2025 -- New Jersey, US -- Tonix Pharmaceuticals Holding Corp, a fully integrated biotechnology company with marketed products and a pipeline of development candidates, today announced that Seth...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 14, 2025